Helen Torley

Track

Insider profile

Currently holds positions in Onyx Pharmaceuticals Inc, Quest Diagnostics Inc and Halozyme Therapeutics, Inc.

Performance

Overall performance
3.3
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 33% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 357%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Executive Vice President, Chief Commercial Officer Onyx Pharmaceuticals Inc Aug. 31, 2011 -
Independent Director Quest Diagnostics Inc Jan. 1, 2018 -
President, Chief Executive Officer, Director Halozyme Therapeutics, Inc. Jan. 6, 2014 -
Helen Torley's trades of Halozyme Therapeutics, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-11 2026-09-11
PlS Planned sale
64,260 +6.7%
290.87
US$695,488 		64,260 +6.7% 290.87 US$695,488
2026-09-11 2026-09-11
PlS Planned sale
26,807 +49.9%
282.00
US$1,515,054 		26,807 +49.9% 282.00 US$1,515,054
2026-09-11 2026-09-10
PlS Planned sale
16,741 -11.3%
16.23
US$2,129,769 		16,741 -11.3% 16.23 US$2,129,769
2026-09-11 2026-09-10
PlS Planned sale
14,588 -1.9%
107.01
US$1,561,091 		14,588 -1.9% 107.01 US$1,561,091
2026-09-11 2026-09-09
PlS Planned sale
100 -0.0%
108.67
US$10,867 		100 -0.0% 108.67 US$10,867
2026-09-11 2026-09-09
PlS Planned sale
6,596 -0.9%
107.82
US$711,187 		6,596 -0.9% 107.82 US$711,187
2026-09-11 2026-09-09
PlS Planned sale
13,304 -1.7%
107.22
US$1,426,481 		13,304 -1.7% 107.22 US$1,426,481
2026-08-19 2026-08-19
PlS Planned sale
3,200 -0.4%
107.77
US$344,848 		3,200 -0.4% 107.77 US$344,848
2026-08-19 2026-08-19
PlS Planned sale
9,600 -1.2%
107.22
US$1,029,350 		9,600 -1.2% 107.22 US$1,029,350
2026-08-19 2026-08-19
PlS Planned sale
7,200 -0.9%
106.36
US$765,778 		7,200 -0.9% 106.36 US$765,778
2026-08-19 2026-08-18
PlS Planned sale
9,400 -1.2%
104.87
US$985,816 		9,400 -1.2% 104.87 US$985,816
2026-08-19 2026-08-18
PlS Planned sale
4,897 -0.6%
104.11
US$509,827 		4,897 -0.6% 104.11 US$509,827
2026-08-19 2026-08-18
PlS Planned sale
5,703 -0.7%
103.08
US$587,882 		5,703 -0.7% 103.08 US$587,882
2026-08-19 2026-08-17
PlS Planned sale
7,500 -1.0%
103.48
US$776,115 		7,500 -1.0% 103.48 US$776,115
2026-08-19 2026-08-17
PlS Planned sale
9,000 -1.1%
102.55
US$922,977 		9,000 -1.1% 102.55 US$922,977
2026-08-19 2026-08-17
PlS Planned sale
2,100 -0.3%
101.77
US$213,709 		2,100 -0.3% 101.77 US$213,709
2026-08-19 2026-08-17
PlS Planned sale
500 -0.1%
100.46
US$50,228 		500 -0.1% 100.46 US$50,228
2026-08-19 2026-08-17
PlS Planned sale
900 -0.1%
98.96
US$89,062 		900 -0.1% 98.96 US$89,062
2026-08-17 2026-08-17
PrS Proposed sale
240,000
98.66
US$23,678,400 		240,000 98.66 US$23,678,400
2026-07-09 2026-07-08
PlS Planned sale
1,035 -0.1%
80.19
US$82,994 		1,035 -0.1% 80.19 US$82,994
2026-07-09 2026-07-08
PlS Planned sale
888 -0.1%
79.28
US$70,397 		888 -0.1% 79.28 US$70,397
2026-06-03 2026-06-03
PlS Planned sale
6,100 -0.8%
69.69
US$425,121 		6,100 -0.8% 69.69 US$425,121
2026-06-03 2026-06-03
PlS Planned sale
2,000 -0.3%
68.74
US$137,472 		2,000 -0.3% 68.74 US$137,472
2026-06-03 2026-06-03
PlS Planned sale
1,500 -0.2%
67.68
US$101,512 		1,500 -0.2% 67.68 US$101,512
2026-06-03 2026-06-03
PlS Planned sale
400 -0.1%
66.37
US$26,547 		400 -0.1% 66.37 US$26,547
2026-06-03 2026-06-02
PlS Planned sale
3,400 -0.4%
66.75
US$226,933 		3,400 -0.4% 66.75 US$226,933
2026-06-03 2026-06-02
PlS Planned sale
16,600 -2.1%
66.31
US$1,100,812 		16,600 -2.1% 66.31 US$1,100,812
2026-06-03 2026-06-01
PlS Planned sale
5,401 -0.7%
68.35
US$369,137 		5,401 -0.7% 68.35 US$369,137
2026-06-03 2026-06-01
PlS Planned sale
12,989 -1.7%
67.41
US$875,588 		12,989 -1.7% 67.41 US$875,588
2026-06-03 2026-06-01
PlS Planned sale
1,610 -0.2%
66.39
US$106,885 		1,610 -0.2% 66.39 US$106,885
2026-05-13 2026-05-13
PlS Planned sale
600 -0.1%
70.81
US$42,487 		600 -0.1% 70.81 US$42,487
2026-05-13 2026-05-13
PlS Planned sale
3,950 -0.5%
69.79
US$275,659 		3,950 -0.5% 69.79 US$275,659
2026-05-13 2026-05-13
PlS Planned sale
3,350 -0.4%
68.88
US$230,748 		3,350 -0.4% 68.88 US$230,748
2026-05-13 2026-05-13
PlS Planned sale
2,100 -0.3%
68.10
US$143,014 		2,100 -0.3% 68.10 US$143,014
2026-05-13 2026-05-12
PlS Planned sale
2,800 -0.4%
73.12
US$204,739 		2,800 -0.4% 73.12 US$204,739
2026-05-13 2026-05-12
PlS Planned sale
5,900 -0.8%
72.15
US$425,673 		5,900 -0.8% 72.15 US$425,673
2026-05-13 2026-05-12
PlS Planned sale
9,802 -1.2%
71.37
US$699,569 		9,802 -1.2% 71.37 US$699,569
2026-05-13 2026-05-12
PlS Planned sale
1,398 -0.2%
70.29
US$98,261 		1,398 -0.2% 70.29 US$98,261
2026-05-13 2026-05-12
PlS Planned sale
100 -0.0%
67.85
US$6,785 		100 -0.0% 67.85 US$6,785
2026-05-13 2026-05-11
PlS Planned sale
6,700 -0.9%
66.33
US$444,391 		6,700 -0.9% 66.33 US$444,391
2026-05-13 2026-05-11
PlS Planned sale
3,575 -0.5%
65.46
US$234,012 		3,575 -0.5% 65.46 US$234,012
2026-05-13 2026-05-11
PlS Planned sale
9,725 -1.2%
64.63
US$628,536 		9,725 -1.2% 64.63 US$628,536
2026-05-11 2026-05-11
PrS Proposed sale
101,923
64.12
US$6,535,303 		101,923 64.12 US$6,535,303
2026-04-07 2026-04-06
PlS Planned sale
4,100 -0.5%
64.02
US$262,462 		4,100 -0.5% 64.02 US$262,462
2026-04-07 2026-04-06
PlS Planned sale
5,900 -0.8%
63.14
US$372,520 		5,900 -0.8% 63.14 US$372,520